Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 292

    1.

    Impact of office systems and improvement strategies on costs of care for adults with diabetes.

    Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI.

    Diabetes Care. 2006 Jun;29(6):1242-8.PMID: 16732003 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Predictors of health care costs in adults with diabetes.

    Gilmer TP, O'Connor PJ, Rush WA, Crain AL, Whitebird RR, Hanson AM, Solberg LI.

    Diabetes Care. 2005 Jan;28(1):59-64.PMID: 15616234 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Medical costs of managed care in patients with type 2 diabetes mellitus.

    Bhattacharyya SK, Else BA.

    Clin Ther. 1999 Dec;21(12):2131-42.PMID: 10645758 [PubMed - indexed for MEDLINE]Related articles

    5.

    Short-term economic impact of body weight change among patients with type 2 diabetes treated with antidiabetic agents: analysis using claims, laboratory, and medical record data.

    Yu AP, Wu EQ, Birnbaum HG, Emani S, Fay M, Pohl G, Wintle M, Yang E, Oglesby A.

    Curr Med Res Opin. 2007 Sep;23(9):2157-69. Review.PMID: 17669232 [PubMed - indexed for MEDLINE]Related articles

    6.

    The cost to health plans of poor glycemic control.

    Gilmer TP, O'Connor PJ, Manning WG, Rush WA.

    Diabetes Care. 1997 Dec;20(12):1847-53.PMID: 9405905 [PubMed - indexed for MEDLINE]Related articles

    7.

    Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

    Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

    J Manag Care Pharm. 2007 Sep;13(7):561-9.PMID: 17874862 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.

    Khandker RK, Kruzikas DT, McLaughlin TP.

    J Manag Care Pharm. 2008 Jun;14(5):426-41.PMID: 18597572 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Relationship of glycemic control to total diabetes-related costs for managed care health plan members with type 2 diabetes.

    Shetty S, Secnik K, Oglesby AK.

    J Manag Care Pharm. 2005 Sep;11(7):559-64.PMID: 16137213 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

    Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

    J Manag Care Pharm. 2008 Mar;14(2):176-85.PMID: 18331119 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

    Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

    J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Is having a regular provider of diabetes care related to intensity of care and glycemic control?

    O'Connor PJ, Desai J, Rush WA, Cherney LM, Solberg LI, Bishop DB.

    J Fam Pract. 1998 Oct;47(4):290-7.PMID: 9789515 [PubMed - indexed for MEDLINE]Related articles

    13.

    Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.

    Lee WC, Balu S, Cobden D, Joshi AV, Pashos CL.

    Clin Ther. 2006 Oct;28(10):1712-25; discussion 1710-1. Erratum in: Clin Ther. 2006 Nov;28(11):1968-9. PMID: 17157128 [PubMed - indexed for MEDLINE]Related articles

    14.

    Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes.

    Egede LE, Zheng D, Simpson K.

    Diabetes Care. 2002 Mar;25(3):464-70.PMID: 11874931 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The effects of medical group practice and physician payment methods on costs of care.

    Kralewski JE, Rich EC, Feldman R, Dowd BE, Bernhardt T, Johnson C, Gold W.

    Health Serv Res. 2000 Aug;35(3):591-613.PMID: 10966087 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Depression and diabetes: impact of depressive symptoms on adherence, function, and costs.

    Ciechanowski PS, Katon WJ, Russo JE.

    Arch Intern Med. 2000 Nov 27;160(21):3278-85.PMID: 11088090 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    PROPAT: a study to improve the quality and reduce the cost of diabetes care.

    Gagliardino JJ, Olivera E, Etchegoyen GS, Guidi ML, Caporale JE, Martella A, Hera Mde L, Siri F, Bonelli P.

    Diabetes Res Clin Pract. 2006 Jun;72(3):284-91. Epub 2006 Mar 27.PMID: 16564105 [PubMed - indexed for MEDLINE]Related articles

    18.

    Economic costs of diabetes in the U.S. In 2007.

    American Diabetes Association.

    Diabetes Care. 2008 Mar;31(3):596-615. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271. PMID: 18308683 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care.

    Piette JD, Wagner TH, Potter MB, Schillinger D.

    Med Care. 2004 Feb;42(2):102-9.PMID: 14734946 [PubMed - indexed for MEDLINE]Related articles

    20.

    Impact of a managed-Medicare physical activity benefit on health care utilization and costs in older adults with diabetes.

    Nguyen HQ, Ackermann RT, Berke EM, Cheadle A, Williams B, Lin E, Maciejewski ML, LoGerfo JP.

    Diabetes Care. 2007 Jan;30(1):43-8.PMID: 17192331 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data